ASCO GU 2019: Gemcitabine plus axitinib in patients with sarcomatoid renal cell carcinoma (RCC)

Results from this trial for sarcomatoid renal cell carcinoma (RCC) patients were reported at the American Society of Clinical Oncology (ASCO) genitourinary (GU) conference held in San Francisco in February 2019. Because there are limited treatment options for this aggressive form of RCC, the trial was designed to verify anecdotal reports of good responders to […]

read more

Highlights from video expert opinion on kidney cancer from ASCO 2018

The following video clips are useful highlights from video interviews with renal cell carcinoma (RCC) experts from the American Society of Clinical Oncology (ASCO) 2018 annual meeting in Chicago in June 2018. These video interviews were produced by PracticeUpdate. ASCO 2018: Critical practice impacting trials in GU oncology ASCO 2018: An overview of novel immunotherapy […]

read more

Take home messages from ASCO

The American Society of Clinical Oncology (ASCO) annual meeting is the biggest cancer conference in the world. This year’s conference took place in Chicago last week, and attracted more than 35,000 cancer researchers, oncologists, patient advocates, politicians and other major players in pharmaceuticals and biotechnology. One of the hottest topics this year was immunotherapy, with […]

read more
Showing 41 to 43 of 43 results